Pleural Effusion, Malignant

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Rocket Pharmaceuticals
2 programs
Digital Pleural ManometryN/A1 trial
EDIT ManagementN/A1 trial
Active Trials
NCT02805062Unknown65Est. Jul 2017
NCT03319186Unknown30Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rocket PharmaceuticalsEDIT Management
Rocket PharmaceuticalsDigital Pleural Manometry

Clinical Trials (2)

Total enrollment: 95 patients across 2 trials

NCT03319186Rocket PharmaceuticalsEDIT Management

EDIT Management Feasibility Trial

Start: Aug 2017Est. completion: Nov 201830 patients
N/AUnknown
NCT02805062Rocket PharmaceuticalsDigital Pleural Manometry

Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy

Start: Jun 2016Est. completion: Jul 201765 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space